Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (461-470 of 475) with videos related to

Pageof 48
Sort By:
Scientific Reports|January 24, 2017
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociPhilip J Law, Amit Sud, Jonathan S Mitchell, et al.
Leukemia & Lymphoma|January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE studyDaniele Campa, Alessandro Martino, Angelica Macauda, et al.
Nature Communications|September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistanceCirino Botta, Cristina Perez, Marta Larrayoz, et al.
Nature Communications|August 5, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myelomaMolly Went, Laura Duran-Lozano, Gisli H Halldorsson, et al.
International Journal of Cancer|October 9, 2016
Identification of miRSNPs associated with the risk of multiple myelomaAngelica Macauda, Diego Calvetti, Giuseppe Maccari, et al.
Blood Cancer Journal|January 4, 2019
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiologyMolly Went, Amit Sud, Helen Speedy, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.
Nature Communications|July 2, 2016
Genome-wide association study identifies multiple susceptibility loci for multiple myelomaJonathan S Mitchell, Ni Li, Niels Weinhold, et al.
International Journal of Cancer|March 11, 2026
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significanceJosé Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, et al.
Pageof 48

Showing results (461-470 of 475) with videos related to

Sort By:
Pageof 48
Scientific Reports|January 24, 2017
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociPhilip J Law, Amit Sud, Jonathan S Mitchell, et al.
Leukemia & Lymphoma|January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE studyDaniele Campa, Alessandro Martino, Angelica Macauda, et al.
Nature Communications|September 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistanceCirino Botta, Cristina Perez, Marta Larrayoz, et al.
Nature Communications|August 5, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myelomaMolly Went, Laura Duran-Lozano, Gisli H Halldorsson, et al.
International Journal of Cancer|October 9, 2016
Identification of miRSNPs associated with the risk of multiple myelomaAngelica Macauda, Diego Calvetti, Giuseppe Maccari, et al.
Blood Cancer Journal|January 4, 2019
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiologyMolly Went, Amit Sud, Helen Speedy, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.
Nature Communications|July 2, 2016
Genome-wide association study identifies multiple susceptibility loci for multiple myelomaJonathan S Mitchell, Ni Li, Niels Weinhold, et al.
International Journal of Cancer|March 11, 2026
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significanceJosé Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, et al.
Pageof 48